Loading
This page follows insider dealings at EXMceuticals Inc. as filed with SEDI. Nothing new has been filed by managers of EXMceuticals Inc. in twelve months, the latest record being from 28 October 2020.
Over the whole record (from 2020), the tally stands at no purchases and 7 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
21 of 21 declarations
EXMceuticals Inc. is a company focused on the research and development of cannabinoid-based products. It is listed on the XTSE market.